Mark R. Lilly
@Cm Management, Llc
Latest period2024 - Q3ReportedManaged Assets$125.3MTotal holdings64
Assets growth rate14.98%Assets growth rate (2-Q avg)3.26%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Cm Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 64 positions.
Assets under management
The assets under management (AUM) of Cm Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 125.3M in assets, with a quarterly growth rate of 14.98% and a 2-quarter average growth rate of 3.26%. The portfolio is managed by Mark R. Lilly, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
BIDUBaidu Inc
| 0% | $2.594M 30,000 shares@ $86.48 avg price | Exited |
BABAAlibaba Group Hldg Ltd
| 0% | $2.16M 30,000 shares@ $72.0 avg price | Exited |
RVNCRevance Therapeutics Inc
| 0% | $1.028M 400,000 shares@ $2.57 avg price | Exited |
HASHasbro Inc
| 0% | $877,500 15,000 shares@ $58.5 avg price | Exited |
KHCKraft Heinz Co
| 0% | $805,500 25,000 shares@ $32.22 avg price | Exited |
VRNAVerona Pharma Plc
| 0% | $506,100 35,000 shares@ $14.46 avg price | Exited |
GANXGain Therapeutics Inc
| 0% | $115,200 90,000 shares@ $1.28 avg price | Exited |